ProMIS Neurosciences Inc (PMN) Stock Price, Quote, News & History

PMNNASDAQ
$13.56
0.161.19%
At close: Sep 10, 5:00 PM EST
$14.00
0.604.48%
Pre-Market: 4:00 AM EST

ProMIS Neurosciences (PMN) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-42.11M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
91.03M
Free Cash Flow (TTM)
-42.11M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
48.92M

Analyst Trends and Forecast

3
Jun
4
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$69.66M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.49
Earnings Yield % (TTM)
-91.92%
Earnings Yield % (FWD)
-27.17%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.51

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$53.43M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$13.56
Volume / Avg.
62.00 / 86.19K
Day Range
- - -
52 Wk Range
6.27 - 27.40
Market Cap
$125.55M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
2.96%
Days to Cover
9.41

About

Sector
Health Care
Industry
Biotechnology
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic la...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ProMIS Neurosciences (PMN) stock?

A

You can purchase shares of ProMIS Neurosciences (NASDAQ:PMN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ProMIS Neurosciences (PMN) competitors?

Q

What is the forecast, or price target, for ProMIS Neurosciences (PMN) stock?

A

ProMIS Neurosciences has a consensus price target of $73.43.

Q

What is the current price for ProMIS Neurosciences (PMN)?

A

The stock price for ProMIS Neurosciences (NASDAQ: PMN) is $14 last updated September 9, 2026 at 9:00 AM EDT.

Q

Does ProMIS Neurosciences (PMN) pay a dividend?

A

There are no upcoming dividends for ProMIS Neurosciences.

Q

When is ProMIS Neurosciences (NASDAQ:PMN) reporting earnings?

A

ProMIS Neurosciences does not have any upcoming earnings scheduled.

Q

Is ProMIS Neurosciences (PMN) going to split?

A

There is no upcoming split for ProMIS Neurosciences.

Q

What sector and industry does ProMIS Neurosciences (PMN) operate in?

A

ProMIS Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.